4.7 Article

Mitochondrial oxidative stress by Lon-PYCR1 maintains an immunosuppressive tumor microenvironment that promotes cancer progression and metastasis

期刊

CANCER LETTERS
卷 474, 期 -, 页码 138-150

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2020.01.019

关键词

Mitochondrial Lon; PYCR1; ROS; Immunoescape; Tumor microenvironment

类别

资金

  1. Ministry of Science and Technology [MOST 103-2320-B-400-022-MY3, MOST105-2628-B-400-003-MY3, MOST107-2627-M-400-001, MOST108-2320-B-400-008-MY3]
  2. Ministry of Health and Welfare [MOHW106-TDU-B-212-122015]
  3. National Health Research Institutes [108A1-CA-PP-07]

向作者/读者索取更多资源

Mitochondrial Lon is a chaperone protein whose upregulation increases the production of mitochondrial reactive oxygen species (ROS). However, there is a lack of information in detail on how mitochondrial Lon regulates cancer metastasis through ROS production in the tumor microenvironment (TME). Our results show that elevated Lon promotes epithelial-mesenchymal transition (EMT) via ROS-dependent p38 and NF-kappa B-signaling. We further identified pyrroline-5-carboxylate reductase 1 (PYCR1) as a client of chaperone Lon, which induces mitochondria] ROS and EMT by Lon. Mitochondrial Lon induces ROS-dependent production of inflammatory cytokines, such as TGF-beta, IL-6, IL-13, and VEGF-A, which consequently activates EMT, angiogenesis, and M2 macrophage polarization. In addition, Lon expression is induced upon the activation and M2 polarization of macrophages, which further promotes M2 macrophages to enhance the immunosuppressive microenvironment and metastatic behaviors in the TME. This raises the possibility that manipulation of the mitochondrial redox balance in the TME may serve as a therapeutic strategy to improve T cell function in cancer immunotherapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medical Laboratory Technology

A time-saving-modified Giemsa stain is a better diagnostic method of Helicobacter pylori infection compared with the rapid urease test

Chi-Chen Fan, Chung-Hsing Chen, Chi Chou, Ting-Yu Kao, An Ning Cheng, Alan Yueh-Luen Lee, Cheng-Liang Kuo

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)

Article Multidisciplinary Sciences

Ephrin A4-ephrin receptor A10 signaling promotes cell migration and spheroid formation by upregulating NANOG expression in oral squamous cell carcinoma cells

Yu-Lin Chen, Yi-Chen Yen, Chuan-Wei Jang, Ssu-Han Wang, Hsin-Ting Huang, Chung-Hsing Chen, Jenn-Ren Hsiao, Jang-Yang Chang, Ya-Wen Chen

Summary: EPHA10 is implicated in tumor growth and metastasis of oral squamous cell carcinoma, with its ligand EFNA4 inducing cell migration and up-regulation of SNAIL, NANOG, and OCT4. Inhibition of ERK and knockdown of NANOG abolish these effects, suggesting a potential therapeutic target for OSCC.

SCIENTIFIC REPORTS (2021)

Article Oncology

Mitochondrial Lon-induced mtDNA leakage contributes to PD-L1-mediated immunoescape via STING-IFN signaling and extracellular vesicles

An Ning Cheng, Li-Chun Cheng, Cheng-Liang Kuo, Yu Kang Lo, Han-Yu Chou, Chung-Hsing Chen, Yi-Hao Wang, Tsung-Hsien Chuang, Shih-Jung Cheng, Alan Yueh-Luen Lee

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Article Oncology

Establishment of an Immunocompetent Metastasis Rat Model with Hepatocyte Cancer Stem Cells

Semon Wu, I-Chieh Tseng, Wen-Cheng Huang, Cheng-Wen Su, Yu-Heng Lai, Che Lin, Alan Yueh-Luen Lee, Chan-Yen Kuo, Li-Yu Su, Ming-Cheng Lee, Te-Cheng Hsu, Chun-Hsien Yu

CANCERS (2020)

Article Environmental Sciences

Sub-multiplicative interaction between polygenic risk score and household coal use in relation to lung adenocarcinoma among never-smoking women in Asia

Batel Blechter, Jason Y. Y. Wong, Chao Agnes Hsiung, H. Dean Hosgood, Zhihua Yin, Xiao-Ou Shu, Han Zhang, Jianxin Shi, Lei Song, Minsun Song, Wei Zheng, Zhaoming Wang, Neil Caporaso, Laurie Burdette, Meredith Yeager, Sonja I. Berndt, Maria Teresa Landi, Chien-Jen Chen, Gee-Chen Chang, Chin-Fu Hsiao, Ying-Huang Tsai, Kuan-Yu Chen, Ming-Shyan Huang, Wu-Chou Su, Yuh-Min Chen, Li-Hsin Chien, Chung-Hsing Chen, Tsung-Ying Yang, Chih-Liang Wang, Jen-Yu Hung, Chien-Chung Lin, Reury-Perng Perng, Chih-Yi Chen, Kun-Chieh Chen, Yao-Jen Li, Chong-Jen Yu, Yi-Song Chen, Ying-Hsiang Chen, Fang-Yu Tsai, Wei Jie Seow, Bryan A. Bassig, Wei Hu, Bu-Tian Ji, Wei Wu, Peng Guan, Qincheng He, Yu-Tang Gao, Qiuyin Cai, Wong-Ho Chow, Yong-Bing Xiang, Dongxin Lin, Chen Wu, Yi-Long Wu, Min-Ho Shin, Yun-Chul Hong, Keitaro Matsuo, Kexin Chen, Maria Pik Wong, Daru Lu, Li Jin, Jiu-Cun Wang, Adeline Seow, Tangchun Wu, Hongbing Shen, Joseph F. Fraumeni, Pan-Chyr Yang, I-Shou Chang, Baosen Zhou, Stephen J. Chanock, Nathaniel Rothman, Nilanjan Chatterjee, Qing Lan

Summary: The study identified interactions between genetic susceptibility and coal use in Asian women, showing weaker genetic susceptibility to lung adenocarcinoma among never-smoking women who use coal. This suggests potential differences in lung cancer pathogenesis based on exposure to coal combustion products, with novel findings of sub-multiplicative gene-environment interactions in the cancer literature.

ENVIRONMENT INTERNATIONAL (2021)

Article Cell Biology

Lon upregulation contributes to cisplatin resistance by triggering NCLX-mediated mitochondrial Ca2+ release in cancer cells

Vidhya Tangeda, Yu Kang Lo, Ananth Ponneri Babuharisankar, Han-Yu Chou, Cheng-Liang Kuo, Yung-Hsi Kao, Alan Yueh-Luen Lee, Jang-Yang Chang

Summary: Mitochondrial Lon plays a crucial role in cisplatin-induced mtDNA damage and oxidative stress by modulating calcium levels, resulting in increased resistance of cancer cells to cisplatin treatment.

CELL DEATH & DISEASE (2022)

Article Oncology

A Fc-VEGF chimeric fusion enhances PD-L1 immunotherapy via inducing immune reprogramming and infiltration in the immunosuppressive tumor microenvironment

Cheng-Liang Kuo, Han-Yu Chou, Hui-Wen Lien, Chia-An Yeh, Jing-Rong Wang, Chung-Hsing Chen, Chi-Chen Fan, Chih-Ping Hsu, Ting-Yu Kao, Tai-Ming Ko, Alan Yueh-Luen Lee

Summary: Fc-VEGF fusion antibody drug normalizes intratumor vasculature to reprogram the immunosuppressive tumor microenvironment, enhancing cancer immunotherapy.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)

Article Oncology

Recalibrating Risk Prediction Models by Synthesizing Data Sources: Adapting the Lung Cancer PLCO Model for Taiwan

Li-Hsin Chien, Tzu-Yu Chen, Chung-Hsing Chen, Kuan-Yu Chen, Chin-Fu Hsiao, Gee-Chen Chang, Ying-Huang Tsai, Wu-Chou Su, Ming-Shyan Huang, Yuh-Min Chen, Chih-Yi Chen, Sheng-Kai Liang, Chung-Yu Chen, Chih-Liang Wang, Hsiao-Han Hung, Hsin-Fang Jiang, Jia-Wei Hu, Nathaniel Rothman, Qing Lan, Tsang-Wu Liu, Chien-Jen Chen, Pan-Chyr Yang, I-Shou Chang, Chao A. Hsiung

Summary: This study proposes methods for adapting risk models for populations without prospective cohorts, using the example of adapting a lung cancer risk model in Taiwan. The adapted models show high performance in calibration and clinical usefulness.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

Article Oncology

Chemoresistance in acute myeloid leukemia: An alternative single-cell RNA sequencing approach

Po-Liang Cheng, Tzu-Hung Hsiao, Chung-Hsing Chen, Miao-Neng Hung, Pei-Pei Jhan, Li-Wen Lee, Ting-Shuan Wu, Jia-Rung Tsai, Chieh-Lin Jerry Teng

Summary: This study aimed to identify potential mechanisms of chemoresistance of the 7 + 3 induction in acute myeloid leukemia (AML) cells using a single-cell RNA sequencing (scRNA-seq) approach. The results showed that chemoresistant AML cells had premature accumulation during early hematopoiesis and expressed more leukemic stem cell markers than chemosensitive cells. In addition, patients with higher expression of chemoresistant genetic markers had worse overall survival.

HEMATOLOGICAL ONCOLOGY (2023)

Article Cell Biology

Mitochondrial Lon-induced mitophagy benefits hypoxic resistance via Ca2+-dependent FUNDC1 phosphorylation at the ER-mitochondria interface

Ananth Ponneri Babuharisankar, Cheng-Liang Kuo, Han-Yu Chou, Vidhya Tangeda, Chi-Chen Fan, Chung-Hsing Chen, Yung-Hsi Kao, Alan Yueh-Luen Lee

Summary: During hypoxia, FUNDC1 acts as a mitophagy receptor and accumulates at the ER-mitochondria contact sites (EMC). This study explores the mechanism of how mitochondrial sensors trigger and stabilize the FUNDC1-ULK1 complex by chaperone Lon in the EMC for cell survival and cancer progression. It is found that Lon induces mitophagy through binding with mitochondrial Na+/Ca2+ exchanger (NCLX) to promote FUNDC1-ULK1-mediated mitophagy at the EMC site.

CELL DEATH & DISEASE (2023)

Review Cell Biology

Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?

Cheng-Liang Kuo, Ananth Ponneri Babuharisankar, Ying-Chen Lin, Hui-Wen Lien, Yu Kang Lo, Han-Yu Chou, Vidhya Tangeda, Li-Chun Cheng, An Ning Cheng, Alan Yueh-Luen Lee

Summary: Oxidative stress is characterized by an excessive level of reactive oxygen species (ROS) generated from vigorous metabolism and oxygen consumption. The precise balance of oxidative stress between mitochondria and other organelles is crucial for cell survival. ROS produced from mitochondria play a major role in tumorigenesis, affecting various aspects such as proliferation, migration/invasion, angiogenesis, inflammation, and immunoescape. The dynamic balance of oxidative stress not only orchestrates complex cell signaling events in cancer cells but also influences the tumor microenvironment (TME), particularly immune cells.

JOURNAL OF BIOMEDICAL SCIENCE (2022)

Review Oncology

Small extracellular vesicles: Non-negligible vesicles in tumor progression, diagnosis, and therapy

Xinru Zhou, Yin Jia, Chuanbin Mao, Shanrong Liu

Summary: Small extracellular vesicles (sEVs), such as exosomes, have emerged as crucial targets for liquid biopsy and promising drug delivery vehicles in tumor progression. They can serve as biomarkers for tumor diagnosis and as drug carriers for cancer treatment.

CANCER LETTERS (2024)

Article Oncology

HMGB1 in the interplay between autophagy and apoptosis in cancer

Ruochan Chen, Ju Zhu, Xiao Zhong, Jie Li, Rui Kang, Daolin Tang

Summary: The interplay between autophagy and apoptosis plays a crucial role in tumorigenesis and cancer therapy, with HMGB1 serving as a key regulator in these processes.

CANCER LETTERS (2024)

Article Oncology

Epigenetic inhibition of CTCF by HN1 promotes dedifferentiation and stemness of anaplastic thyroid cancer

Zongfu Pan, Xixuan Lu, Tong Xu, Jinming Chen, Lisha Bao, Ying Li, Yingying Gong, Yulu Che, Xiaozhou Zou, Zhuo Tan, Ping Huang, Minghua Ge

Summary: This study uncovered the emerging role of HN1 in promoting dedifferentiation of anaplastic thyroid cancer (ATC) cells. HN1 negatively regulated the thyroid differentiation markers and had an inhibitory effect on the transcriptional activation of CTCF, thereby influencing the chromatin accessibility of thyroid differentiation genes.

CANCER LETTERS (2024)

Article Oncology

Autophagy machinery in glioblastoma: The prospect of cell death crosstalk and drug resistance with bioinformatics analysis

Yi Qin, Shengjun Xiong, Jun Ren, Gautam Sethi

Summary: Autophagy plays an important regulatory role in glioblastoma, and its dysregulation can lead to drug resistance and radioresistance. It also affects stem cell characteristics, overall growth, and metastasis. Therefore, autophagy is a promising target for glioblastoma therapy.

CANCER LETTERS (2024)

Article Oncology

Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase

Katsuya Nagaoka, Xuewei Bai, Dan Liu, Kevin Cao, Joud Mulla, Chengcheng Ji, Hongze Chen, Muhammad Azhar Nisar, Amalia Bay, William Mueller, Grace Hildebrand, Jin-Song Gao, Shaolei Lu, Hiroko Setoyama, Yasuhito Tanaka, Jack R. Wands, Chiung-Kuei Huang

Summary: This study found that serum 2-OG levels in cholangiocarcinoma patients are associated with the effectiveness of chemotherapy. Patients with progressive disease showed significantly higher levels of serum 2-OG compared to stable disease and partial response patients. The study also revealed that overexpression of ASPH mimics the effects of 2-OG, and knockdown of ASPH improves chemotherapy. Targeting ASPH enhances the effects of chemotherapy by modulating ATM and ATR, two key regulators of DDRs.

CANCER LETTERS (2024)